Position in VCYT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$649,671
-$339,518 QoQ
Shares Held
11,062
-69.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#202
of 367 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $15,330,453 across 13 Diagnostics & Research names. VCYT ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
4,967 | $2,614,827 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,373 | $2,192,447 | |
| 3 | GH |
Guardant Health, Inc.
|
14,194 | $2,129,525 | |
| 4 | NTRA |
Natera, Inc.
|
5,952 | $1,615,670 | |
| 5 | ICLR |
Icon PLC
|
8,750 | $1,519,962 | |
| 6 | DHR |
Danaher Corp /De/
|
7,453 | $1,419,647 | |
| 7 | ILMN |
Illumina, Inc.
|
5,605 | $985,527 | |
| 8 | VCYT |
Veracyte, Inc.
This page
|
11,062 | $649,671 |
All Filings in VCYT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $649,671 | 11,062 | Shares | Sole | 2026-08-04 | |
| 2025-06-30 | $989,189 | 36,596 | Shares | Sole | 2025-08-06 | |
| 2024-09-30 | $306,734 | 9,011 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $208,617 | 9,627 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $378,152 | 13,746 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $810,260 | 34,145 | Shares | Sole | 2023-02-07 | |
| 2021-12-31 | $327,540 | 7,950 | Shares | Sole | 2022-02-09 | |
| 2021-06-30 | $283,418 | 7,089 | Shares | Sole | 2021-08-05 | |
| 2020-12-31 | $272,595 | 5,570 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||